INDIANAPOLIS, May 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and SiteOne Therapeutics, Inc. ("SiteOne"), a private biotechnology company developing small molecule inhibitors of ...

Then Ghalichi became better known as a beauty mogul thanks to her luxury lash brand, Lilly Lashes, becoming a must-have for Hollywood’s elite. But behind her signature glam look is a sharp ...

INDIANAPOLIS and WEST LAFAYETTE, May 9, 2025 — Eli Lilly and Company (NYSE: LLY) and Purdue University announced Friday (May 9) a significant expansion of their long-standing alliance, with Lilly’s ...

Eli Lilly and Co. and Purdue University announced today a significant expansion of their long-standing alliance, with Lilly’s planned investment of up to $250 million in the collaboration over ...

Eli Lilly (NYSE:LLY) said Thursday that Ilya Yuffa, executive vice president and president, Lilly International, will become executive vice president and president, Lilly USA and Global Customer ...

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced executive leadership transitions that will further enhance the company's ability to drive sustained ...

Patricia Clarkson plays the equal pay activist Lilly Ledbetter in this misty-eyed drama. By Beatrice Loayza When you purchase a ticket for an independently reviewed film through our site ...

Shop vibrant dresses, standout activewear, and iconic Lilly Pulitzer prints for 60% off—only for 48 hours. Grab your Lilly Pop-Up Sale favorites now before sizes and styles start selling out fast.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Eli Lilly & Co. plans to manufacture its new weight-loss pill in the US for patients around the world as President Donald Trump presses companies to move production back to American shores.

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.